Shree Ganesh [SGRL] vs Innova Captab [INNOVACAP] Detailed Stock Comparison

Shree Ganesh Remedies Ltd.

BSE
Loading...

Innova Captab Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Shree Ganesh Remedies Ltd. wins in 10 metrics, Innova Captab Ltd. wins in 9 metrics, with 0 ties. Shree Ganesh Remedies Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Shree Ganesh Remedies Ltd. Innova Captab Ltd. Better
P/E Ratio (TTM) 37.03 31.20 Innova Captab Ltd.
Price-to-Book Ratio 4.36 4.05 Innova Captab Ltd.
Debt-to-Equity Ratio 24.45 32.95 Shree Ganesh Remedies Ltd.
PEG Ratio -0.86 1.33 Innova Captab Ltd.
EV/EBITDA 18.54 20.49 Shree Ganesh Remedies Ltd.
Profit Margin (TTM) 17.99% 8.85% Shree Ganesh Remedies Ltd.
Operating Margin (TTM) 19.25% 12.88% Shree Ganesh Remedies Ltd.
EBITDA Margin (TTM) 19.25% 12.88% Shree Ganesh Remedies Ltd.
Return on Equity 15.89% 13.37% Shree Ganesh Remedies Ltd.
Return on Assets (TTM) 12.02% 8.12% Shree Ganesh Remedies Ltd.
Free Cash Flow (TTM) $74.69M $-1.09B Shree Ganesh Remedies Ltd.
Dividend Yield N/A 0.30% N/A
1-Year Return 6.66% -3.19% Shree Ganesh Remedies Ltd.
Price-to-Sales Ratio (TTM) 6.66 2.76 Innova Captab Ltd.
Enterprise Value $6.74B $43.41B Innova Captab Ltd.
EV/Revenue Ratio 6.70 2.90 Innova Captab Ltd.
Gross Profit Margin (TTM) 70.00% 35.19% Shree Ganesh Remedies Ltd.
Revenue per Share (TTM) $78 $262 Innova Captab Ltd.
Earnings per Share (Diluted) $14.09 $23.16 Innova Captab Ltd.
Beta (Stock Volatility) 0.19 -0.33 Innova Captab Ltd.

Shree Ganesh Remedies Ltd. vs Innova Captab Ltd. Stock Performance Analysis

Loading Price Chart...

SGRL
INNOVACAP

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Shree Ganesh Remedies Ltd.0.23%0.24%33.57%29.81%39.51%46.20%
Innova Captab Ltd.-0.63%2.24%2.13%29.82%21.15%16.79%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Shree Ganesh Remedies Ltd.6.66%81.76%96.30%1,867.73%1,867.73%1,867.73%
Innova Captab Ltd.-3.19%57.07%57.07%57.07%57.07%57.07%

Performance & Financial Health Analysis: Shree Ganesh Remedies Ltd. vs Innova Captab Ltd.

MetricSGRLINNOVACAP
Market Information
Market Cap i₹6.70B₹41.43B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i4,488578,151
90 Day Avg. Volume i4,536217,693
Last Close₹652.25₹857.00
52 Week Range₹381.10 - ₹665.00₹622.00 - ₹1,020.70
% from 52W High-1.92%-16.04%
All-Time High₹950.05 (Jul 22, 2024)₹1,260.00 (Jan 06, 2025)
% from All-Time High-31.35%-31.98%
Growth Metrics
Quarterly Revenue Growth-0.22%0.42%
Quarterly Earnings Growth-0.43%0.23%
Financial Health
Profit Margin (TTM) i0.18%0.09%
Operating Margin (TTM) i0.19%0.13%
Return on Equity (TTM) i0.16%0.13%
Debt to Equity (MRQ) i24.4532.95
Cash & Liquidity
Book Value per Share (MRQ)₹119.59₹178.28
Cash per Share (MRQ)₹26.25₹10.22
Operating Cash Flow (TTM) i₹337.14M₹282.88M
Levered Free Cash Flow (TTM) i₹230.68M₹1.28B
Dividends
Last 12-Month Dividend Yield iN/A0.30%
Last 12-Month Dividend i₹0.00₹2.00

Valuation & Enterprise Metrics Analysis: Shree Ganesh Remedies Ltd. vs Innova Captab Ltd.

MetricSGRL (Apr 24, 2026)INNOVACAP (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i37.0331.20
Forward P/E iN/A21.90
PEG Ratio i-0.861.33
Price to Sales (TTM) i6.662.76
Price to Book (MRQ) i4.364.05
Market Capitalization
Market Capitalization i₹6.70B₹41.43B
Enterprise Value i₹6.74B₹43.41B
Enterprise Value Metrics
Enterprise to Revenue i6.702.90
Enterprise to EBITDA i18.5420.49
Risk & Other Metrics
Beta i0.19-0.33
Book Value per Share (MRQ) i₹119.59₹178.28

Financial Statements Comparison: Shree Ganesh Remedies Ltd. vs Innova Captab Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSGRL (2025)INNOVACAP (2025)
Revenue/Sales i1.07B12.34B
Cost of Goods Sold i361.73M8.38B
COGS % of Revenue i34.0%67.9%
Gross Profit i703.31M3.96B
Gross Margin i66.0%32.1%
Research & Development i2.65MN/A
Operating Income (EBIT) i301.91M1.65B
Operating Margin i28.3%13.4%
EBITDA i420.76M2.00B
EBITDA Margin i39.5%16.2%
Pre-Tax Income i312.68M1.71B
Pre-Tax Income % of Revenue i29.4%13.9%
Income Tax i81.99M427.58M
Income Tax % of Revenue i7.7%3.5%
Net Income (Profit) i230.68M1.28B
Profit Margin i21.7%10.4%

Balance Sheet & Liquidity Metrics

MetricSGRL (2025)INNOVACAP (2025)
Cash & Equivalents i99.43M155.19M
Total Current Assets i775.75M7.03B
Total Current Assets % of Revenue i72.8%57.0%
Total Current Liabilities i161.82M3.53B
Total Current Liabilities % of Revenue i15.2%28.6%
Long-Term Debt i296.08M2.45B
Long-Term Debt % of Revenue i27.8%19.8%
Total Shareholders Equity i1.45B9.59B
Retained Earnings i1.10B4.53B
Retained Earnings % of Revenue i103.1%36.7%
Property, Plant & Equipment i31.57M442.93M

Cash Flow Statement Comparison

MetricSGRL (2025)INNOVACAP (2025)
Operating Cash Flow i337.14M282.88M
Operating Cash Flow % of Revenue i31.7%2.3%
Capital Expenditures i-231.76M-1.72B
Free Cash Flow i74.69M-1.09B
FCF Margin i7.0%-8.8%
Debt Repayment iN/A-114.03M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSGRLINNOVACAP
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i12.84M57.22M
Float Shares i3.09M15.91M
% Held by Insiders i75.92%72.19%
% Held by Institutions i0.00%19.22%
% Held by Public i24.08%8.59%

Dividend Analysis & Yield Comparison: Shree Ganesh Remedies Ltd. vs Innova Captab Ltd.

MetricSGRLINNOVACAP
Last 12-Month Dividend i₹0.00₹2.00
Last 12-Month Dividend Yield iN/A0.30%
3-Year Avg Annual Dividend i₹0.33₹0.67
3-Year Avg Dividend Yield i0.15%0.30%
3-Year Total Dividends i₹1.00₹2.00
Ex-Dividend DateSep 07, 2023Jan 30, 2026